| 000 | 01342 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512231830.0 | ||
| 264 | 0 | _c19830119 | |
| 008 | 198301s 0 0 eng d | ||
| 022 | _a0091-3952 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeckman, J F | |
| 245 | 0 | 0 |
_aClonidine in the treatment of Tourette syndrome: a review of data. _h[electronic resource] |
| 260 |
_bAdvances in neurology _c1982 |
||
| 300 |
_a391-401 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aBiomechanical Phenomena |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aClonidine _xadministration & dosage |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aGrowth Hormone _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethoxyhydroxyphenylglycol _xblood |
| 650 | 0 | 4 | _aNeurochemistry |
| 650 | 0 | 4 |
_aSympathetic Nervous System _xphysiopathology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTourette Syndrome _xdrug therapy |
| 700 | 1 | _aCohen, D J | |
| 700 | 1 | _aDetlor, J | |
| 700 | 1 | _aYoung, J G | |
| 700 | 1 | _aHarcherik, D | |
| 700 | 1 | _aShaywitz, B A | |
| 773 | 0 |
_tAdvances in neurology _gvol. 35 _gp. 391-401 |
|
| 999 |
_c6755869 _d6755869 |
||